Neuland Laboratories has announced a board meeting on the financial results for the quarter and half-year.

The company reported a standalone profit of ₹259.43 Cr and consolidated profit of ₹260.11 Cr for FY 2024-25, with earnings per share around ₹202. The Board plans a final dividend of ₹12 per equity share, subject to shareholder approval.

Shareholders eligible for the dividend must hold shares by the record date, with payment after the AGM.

This final dividend offers a solid payout reflecting the company’s strong annual performance.